These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9416381)

  • 1. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
    Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
    Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
    Clark CK; Merritt AM; Burrow JA; Steible CK
    J Am Vet Med Assoc; 1996 May; 208(10):1687-91. PubMed ID: 8641951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro bile acid adsorption by bismuth subsalicylate and montmorillonite.
    Kocoshis SA; Ghent CN; Gryboski JD
    Dig Dis Sci; 1984 Dec; 29(12):1148-52. PubMed ID: 6499633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
    Rambout L; Sahai J; Gallicano K; Oliveras L; Garber G
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2187-90. PubMed ID: 7811043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture.
    Albert KS; Welch RD; DeSante KA; DiSanto AR
    J Pharm Sci; 1979 May; 68(5):586-8. PubMed ID: 435335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication.
    Spénard J; Aumais C; Massicotte J; Brunet JS; Tremblay C; Grace M; Lefebvre M
    Br J Clin Pharmacol; 2005 Oct; 60(4):374-7. PubMed ID: 16187969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of metronidazole, tetracycline and bismuth in healthy volunteers after oral administration of compound tablets containing a combination of metronidazole, tetracycline hydrochloride and bismuth oxide.
    Wu Y; Ding L; Huang NY; Wen AD; Liu B; Li WB
    Drug Res (Stuttg); 2015 Feb; 65(2):74-81. PubMed ID: 24764254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.
    Mahony DE; Woods A; Eelman MD; Burford N; Veldhuyzen van Zanten SJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):431-3. PubMed ID: 15616328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.
    Willhite CC; Ball GL; McLellan CJ
    Crit Rev Toxicol; 2012 May; 42(5):358-442. PubMed ID: 22512666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and characterization of taste masked ondansetron-magnesium aluminum silicate adsorption systems.
    Kharb V; Saharan VA; Kharb V; Jadhav H; Purohit S
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1291-9. PubMed ID: 26641930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
    Meyer JM; Ryu S; Pendland SL; Danziger LH
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1607-8. PubMed ID: 9210696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.
    Dy RM; Lof J; DiBaise JK; Quigley EM
    Dig Dis Sci; 1999 Feb; 44(2):286-9. PubMed ID: 10063913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
    Suarez FL; Furne JK; Springfield J; Levitt MD
    Gastroenterology; 1998 May; 114(5):923-9. PubMed ID: 9558280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.
    DuPont HL; Flores Sanchez J; Ericsson CD; Mendiola Gomez J; DuPont MW; Cruz Luna A; Mathewson JJ
    Am J Med; 1990 Jun; 88(6A):15S-19S. PubMed ID: 2192553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
    Koulinska I; Riester K; Chalkias S; Edwards MR
    Clin Ther; 2018 Dec; 40(12):2021-2030.e1. PubMed ID: 30447891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of a calcium carbonate-bismuth subsalicylate combination on intragastric acidity over the course of 24 hours. A randomized study of healthy probands].
    Hopert R; Emde C; Barner M; Vallo-Wermes M; Riecken EO
    Med Klin (Munich); 1989 Mar; 84(3):135-8. PubMed ID: 2716711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylate absorption from a bismuth subsalicylate preparation.
    Feldman S; Chen SL; Pickering LK; Cleary TG; Ericsson CD; Hulse M
    Clin Pharmacol Ther; 1981 Jun; 29(6):788-92. PubMed ID: 7226711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.